Showing 369–384 of 403 items from the last 14 days
SanDisk's Optimus GX C50 expansion cards for Xbox Series X|S are now available on Amazon starting at $249.99 for 1TB, providing the first major alternative to Seagate and Western Digital five years after console launch. This entry by a third-party manufacturer increases competition in proprietary console storage, potentially lowering prices and improving consumer choice.
Read original →Taiwan's projected 11% GDP growth is unsustainable due to risks including capex slowdown, macroeconomic downturns, and concentration in semiconductors, according to economists. Taiwan's semiconductor dominance means its growth volatility directly affects global chip supply, technology capex cycles, and equipment demand from companies like TSMC and Samsung.
Read original →Goliath Resources' drill hole GD-26-436 at the Surebet discovery in British Columbia's Golden Triangle intersected gold-equivalent grades of 19.51 g/t over 8.32 meters, with the zone remaining open for expansion. High-grade gold discoveries near surface indicate exploration success that could support future production and meet growing gold demand from electronics and renewable energy applications.
Read original →We're already waiting for the new gen-AI-powered Siri, but a home hub may be on the way as well.
Read original →Year after year, investors who've explored the Expo Halls, met founders, and learned from peers have proven why you need to be on the ground at Disrupt this year.
Read original →Bessent and President Donald Trump unveiled the economic operation nearly six months into the Iran war, which continues without a clear end in sight.
Read original →1911 Gold Corporation (“1911 Gold” or the “Company“) (TSXV: AUMB) (OTCBB: AUMBF) (FRA: 2KY) is pleased to...
Read original →Three-quarters of organizations have found AI layoffs cost more than they saved, and as many as nine in 10 companies would rethink them given the chance.
Read original →ChatGPT and other AI models are now authoring and editing much of the new web.
Read original →Bitcoin is trading at its highest levels since early June as crypto execs joined with President Donald Trump push to get the Clarity Act over the finish line.
Read original →Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company“) has...
Read original →If you're not happy with the algorithm on your Discover page, you can now tell Google what you want in your own words.
Read original →The 2023 Framework Laptop 13 with AMD Ryzen 7040-series chips. | Photo by Amelia Holowaty Krales / The Verge Some Framework Laptop 13 owners with last-gen AMD chips have reported that a recent BIOS update is bricking their laptops on both Windows and Linux. The BIOS update causing this issue is version 3.20 for Ryzen 7040-series mainboards, released back in July and still available on Framework's site at the time of this writing. Upon running the update, some users reported their laptops getting stuck on the update screen. While some users on Framework's community forums reported that the company was sending them replacement mainboards under the one-year warranty, several with out-of-warranty boards said they were told they'd have to buy new ones. … Read the full story at The Verge.
Read original →With less than three months until the midterm elections, opposition to AI data centers is becoming a bipartisan rallying cry in a growing number of states.
Read original →An experimental personalized mRNA vaccine developed by Moderna (NASDAQ:MRNA) and Merck & Company (NYSE:MRK) successfully prevented skin cancer from returning in a late-stage clinical trial, sending shares of both drugmakers surging on Wednesday (August 19). The Phase 3 study evaluated the personalized vaccine, named intismeran, in combination with Merck’s immunotherapy drug Keytruda against Keytruda alone in 1,137 high-risk melanoma patients who had undergone surgery to remove their tumors. The combination regimen met its primary endpoint by significantly extending recurrence-free survival and achieved its secondary goal of reducing the risk of cancer metastasizing to distant organs. The findings sparked a massive rally for both companies. Moderna shares surged as much as 177 percent to a two-year high of US$174.93, adding roughly US$30 billion to the company's market capitalization as trading volume topped 15 times its 50-day average. Merck rallied by 12 percent to reach an all-time high of US$153.13. Broader sector sentiment climbed alongside the news, lifting the Nasdaq Biotechnology Index up to 5.2 percent to a record high. Moderna and Merck plan to present detailed data at an upcoming medical meeting and have initiated discussions with regulatory agencies. Moderna President Stephen Hoge said the treatment could reach the market as soon as next year under its existing breakthrough therapy designation. Unlike traditional one-size-fits-all oncology treatments, the therapy creates intismeran–the mRNA cancer vaccine–by surgically removing a piece of a patient's tumor and sequencing its DNA to identify unique cellular mutations. Using mRNA technology, the bespoke vaccine instructs the patient's cells to reproduce copies of those specific mutations, training the immune system to recognize and attack any remaining cancer cells displaying those markers when paired with Keytruda. "This is the first time that we've seen really clinically significant, statistically significant improvements over checkpoints like Keytruda in this population, and it is the first time we've done that with an individualized treatment," Hoge said. The drugmakers are currently running clinical trials testing similar personalized mRNA regimens against lung, kidney, bladder, breast, and pancreatic cancers. As of 10:50 a.m. EST shares of Moderna were priced at US$141.69 and Merck was trading for US$150.51. Don’t forget to follow us @INN_LifeScience for real-time news updates! Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Read original →Google built a special exercise experience into the Pixel Watch 5 to make strength training a little less daunting.
Read original →
DailySand